Medicare and Medicaid Services Administrator Dr. Mehmet Oz announced that the Trump administration has expanded its drug-price transparency platform by including 160 more medicines. Starting July 1, eligible Medicare beneficiaries can access specific weight-loss drugs for $50 per month. Dr. Oz highlighted the administration’s efforts to reduce prescription drug costs, emphasizing the significant savings already benefiting consumers.
The CMS administrator pointed out that many Americans struggle to afford medications, with nearly one in three individuals leaving pharmacies empty-handed due to cost concerns. Dr. Oz also underscored the disparity in drug prices between the U.S. and other countries, noting that Americans pay about three times more for the same medications manufactured in the same facilities.
Furthermore, Dr. Oz mentioned that the administration successfully negotiated with 17 major pharmaceutical companies to implement a “most favored nation drug pricing strategy.” This initiative is estimated to generate approximately $600 billion in savings over the next decade. Additionally, he revealed that the administration has added a total of over 750 drugs to its prescription pricing website, enabling consumers to compare prices before making purchases.
Moreover, Dr. Oz highlighted the reduced costs for Medicare beneficiaries prescribed GLP-1 medicines for weight loss. Starting July 1st, eligible Medicare beneficiaries can access these weight-loss products for $50 monthly, significantly lower than the current list prices exceeding $1,000. Dr. Oz emphasized that broader access to these medications could help combat obesity-related conditions, such as diabetes, hypertension, kidney disease, heart disease, and strokes.
In conclusion, Dr. Oz urged Congress to formalize the administration’s drug-pricing agreements to ensure continuity beyond the current administration. He emphasized the importance of simplifying healthcare pricing, enhancing insurance transparency, and implementing reforms for pharmacy benefit managers as part of the broader healthcare agenda.
